Table 2. Recommendations by professional societies.
| Treatment method |
American Academy of Orthopaedic Surgeons
(AAOS 2021) (e5) |
Osteoarthritis Research Society International (OARSI 2019) (4) |
American College of Rheumatology/Arthritis
(ACR 2019) (6) |
European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarhritis and Musculosceletal Diseases
(ESCEO 2019) (5) |
AWMF Guideline knee osteoarthritis/osteoarthritis of the hip (2018/2019) (1, 2) |
| Glucocorticoids | Moderate recommendation (++) (++) |
Moderate recommendation (++) (++) |
Strong recommendation (+++) (+++) |
Limited recommendation (+) |
Moderate recommendation (++) (++) |
| Hyaluronic acid | Moderate recommendation (++) (++) |
Moderate recommendation (++) (++) |
No recommendation (-) (−) |
Limited recommendation (+) |
Moderate recommendation (++) (++) |
| PRP | Limited recommendation (+) |
No recommendation (−) |
No recommendation (-) (−) |
No details | No details for current evidence level |
PRP, platelet rich plasma